Targeting inflammation and collagen metabolism may control fibrotic diseases. Research suggests topical beta-aminopropionitrile (BAPN) could be a practical approach to inhibiting collagen crosslinking and treating fibrosis.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: